Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes

Drug Metabolism and Disposition

Volumn 26, Issue 4, 1998, Pages 305-312

  Draper, Alison J ^b   Madan, Ajay ^b   Latham, Jason ^b   Parkinson, Andrew ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450 ISOENZYME; OXYGENASE;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG HYDROXYLATION; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL;

EID: 0031919787     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Burke MD and Mayer RT (1974) Ethoxyresorufin: Direct fluorometric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2:583-588.
2. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier J-C, Guillouzo A, Beaune P and Berthou F (1993) Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857.
3. Draper A, Madan A and Parkinson A (1996a) Role of CYP2E1 and CYP2A6 in the hydroxylation of 4-nitrophenol by human liver microsomes (Abstract). Toxicologist 30:319.
4. Draper AJ, Madan A and Parkinson A (1996b) Rank order of potency of eight commonly-used inhibitors of human Cytochrome P450 enzymes. Presented at the XI International Symposium on Microsomes and Drug Oxidation, Los Angeles, July, 1996.
5. Dreisbach AW, Ferencz N, Hopkins NE, Fuentes MG, Rege AB, George WJ and Lertora JJL (1995) Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity. Clin Pharmacol Ther 58:498-505.
6. Dutton DR and Parkinson A (1989) Reduction of 7-alkoxyresorufins by NADPH-cytochrome P-450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450. Arch Biochem Biophys 268:617-629.
7. Eckstrom G, von Bahr C and Ingelman-Sundberg M (1989) Human liver microsomal cytochrome P450IIE1: Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction, and NADPH oxidase activity. Biochem Pharmacol 38:689-693.
8. Feierman DE and Cederbaum AI (1987) Increased sensitivity of the microsomal oxidation of ethanol to inhibition by pyrazole and 4-methylpyrazole after chronic ethanol treatment. Biochem Pharmacol 36:3277-3283.
9. Giera DD and van Lier RB (1991) A convenient method for the determination of hepatic lauric acid omega-oxidation based on solvent partition. Fund Appl Toxicol 16:348-355.
10. Gillam EMJ, Guo Z and Guengerich FP (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch Biochem Biophys 312:59-66.
11. Girre C, Lucas D, Hispard E, Menez C, Dally S and Menez JF (1994) Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508.
12. Gu L, Gonzalez FJ, Kalow W and Tang BK (1992) The biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2:73-77.
13. Guengerich FP, Kim DH and Iwasaki M (1991) Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168-179.
14. Halpert JR, Guengerich FP, Bend JR and Correia MA (1994) Selective inhibitors of cytochromes P450. Toxicol Appl Pharmacol 125:163-175.
15. Herbst J, Koster U, Kerssebaum R and Dekant W (1994) Role of P4502E1 in the metabolism of 1,1,2,2-tetrafluoro-1-(2.2,2-trifluoroethoxy)-ethane. Xenobiotica 24:507-516.
16. Kharasch ED and Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevofluorane, isofluorane and methoxyfluorane. Anesthesiology 79:795-807.
17. Kharasch ED, Thummel KE, Mhyre J and Lillibridge JH (1993) Single-dose disulfiram inhibition of chlorzoxazone metabolism: A clinical probe for P4502E1. Clin Pharmacol Ther 53:643-650
18. Kim RB, O'Shea D and Wilkinson GR (1995) Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 57:645-655.
19. Koop DR (1992) Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 6:724-730.
20. Koop DR and Tierney DJ (1990) Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. BioEssays 12:429-435.
21. 14C]halothane to human liver microsomes: A role for CYP2E1 at low substrate concentrations. Drug Metab Dispos 24:1307-1313.
22. Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD and Slattery JT (1995) Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther 58:556-566.
23. Murray BP, Edwards RJ, Murray S, Singleton AM, Davies DS and Boobis AR (1993) Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 14:585-592.
24. Nesnow S, Fahl WE and Jefcoate CR (1977) An improved radiochemical assay for benzopyrene monooxygenase. Anal Biochem 80:258-266.
25. Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T and Gonzalez FJ (1995) Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5:143-150.
26. O'Shea D, Davis SN, Kim RB and Wilkinson GR (1994) Effect of fasting and obesity in human on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clin Pharmacol Ther 56:359-367.
27. Parkinson A (1996) Biotransformation of xenobiotics, in Casarett and Doull's Toxicology: The Basic Science of Poisons (Klaassen CD ed) 5th Ed., pp 113-186, McGraw Hill, New York.
28. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP and Yang CS (1993) Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 6:511-518.
29. Pearce RE, Coulter CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C and Parkinson A (1996) Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys 331:145-169.
30. Perrot N, Nalpas B, Yang CS and Beaune PH (1989) Modulation of cytochrome P450 isozymes in human liver by ethanol and drug intake. Eur J Clin Invest 22:147-159.
31. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566-573.
32. Raucy JL, Lasker JM, Lieber CS and Black M (1989) Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 271:270-283.
33. Schweikl H, Taylor JA, Kitareewan S, Linko P, Nagorney D and Goldstein JA (1993) Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3:329-240.
34. Song BJ, Veech RL and Saenger P (1990) Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J Clin Endocrinol Metab 71:1036-1040.
35. Surbrook SE Jr and Olson MJ (1992) Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane. Drug Metab Dispos 20:518-524.
36. Tassaneeyakul W, Veronese ME, Birkett DJ and Miners JO (1993a) High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes. J Chromatogr 616:73-78.
37. Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ and Miners JO (1993b) Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Biochem Pharmacol 46:1975-1981.
38. Tassaneeyakul W, Birkett DJ, McManus ME, Tassaneeyakul W, Veronese ME, Andersson T, Tukey RH and Miners MO (1994) Caffeine metabolism by human hepatic cytochromes P450: Contributions of 1A2, 2E1 and 3A isoforms. Biochem Pharmacol 47:1767-1776.
39. Thummel KE, Kharasch ED, Podoll T and Kunze K (1993) Human liver microsomal enflurane defluorination catalyzed by cytochrome P450 2E1. Drug Metab Dispos 21:350-357.
40. Tomaszewski JE, Jerina DM, Levin W and Conney AH (1976) A highly sensitive radiometric assay for zoxazolamine hydroxylation by liver microsomal cytochrome P-450 and P-448: Properties of the membrane-bound and purified reconstituted system. Arch Biochem Biophys 176:788-798.
41. Yamazaki H, Guo Z and Guengerich FP (1995) Selectivity of cytochrome P452E1 in chlorzoxazone 6-hydroxylation. Drug Metab Dispos 23:438-439.
42. Yang CS, Yoo JSH, Ishizaki H and Hong J (1990) Cytochrome P450IIE1: Roles of nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 22:147-159.